Transition of care to prevent recurrence after acute coronary syndrome: the critical role of the primary care provider and pharmacist

References

• Amsterdam EA, Wenger NK, Brindis RG, et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228.
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
   PubMed Web of Science ®Google Scholar
• Abu-Assi E, Lopez-Lopez A, Gonzalez-Salvado V, et al. The risk of cardiovascular events after an acute coronary event remains high, especially during the first year, despite revascularization. Rev Esp Cardiol (Engl Ed). 2016;69(1):11–18.
   PubMed Web of Science ®Google Scholar
• Doost Hosseiny A, Moloi S, Chandrasekhar J, et al. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart. 2016;3(1):e000405.
   PubMed Web of Science ®Google Scholar
• Norgaard ML, Andersen SS, Schramm TK, et al. Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction–a nationwide study. Diabetologia. 2010;53(8):1612–1619.
   PubMed Web of Science ®Google Scholar
• Rapsomaniki E, Thuresson M, Yang E, et al. Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. 2016;2(3):172–183.
   PubMed Web of Science ®Google Scholar
• Vora AN, Wang TY, Hellkamp AS, et al. Differences in short- and long-term outcomes among older patients with ST-elevation versus non-ST-elevation myocardial infarction with angiographically proven coronary artery disease. Circ Cardiovasc Qual Outcomes. 2016;9(5):513–522.
   PubMed Web of Science ®Google Scholar
• Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–2165.
   PubMed Web of Science ®Google Scholar
• LaMori JC, Shoheiber O, Dudash K, et al. The economic impact of acute coronary syndrome on length of stay: an analysis using the Healthcare Cost and Utilization Project (HCUP) databases. J Med Econ. 2014;17(3):191–197.
   PubMedGoogle Scholar
• Shetty S, Halpern R, McCollam PL. Cost of care for new versus recurrent acute coronary syndrome patients. J Med Econ. 2008;11(1):81–99.
   PubMedGoogle Scholar
• Etemad LR, McCollam PL. Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm. 2005;11(4):300–306.
   PubMedGoogle Scholar
• Yang E, Stokes M, Johansson S, et al. Clinical and economic outcomes among elderly myocardial infarction survivors in the United States. Cardiovasc Ther. 2016;34(6):450–459.
   PubMed Web of Science ®Google Scholar
• Kim LK, Yeo I, Cheung JW, et al. Thirty-day readmission rates, timing, causes, and costs after ST-segment-elevation myocardial infarction in the United States: a national readmission database analysis 2010–2014. J Am Heart Assoc. 2018;7(18):e009863.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Winget M. Economic burden of illness of acute coronary syndromes: medical and productivity costs. BMC Health Serv Res. 2011;11:35.
   PubMed Web of Science ®Google Scholar
• Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015. Circulation. 2017;136(20):1908–1919.
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;61(4):e78–e140.
   PubMed Web of Science ®Google Scholar
• Kripalani S, Henderson LE, Jacobson TA, et al. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008;83(5):529–535.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, et al. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2016;68(10):1082–1115.
   PubMed Web of Science ®Google Scholar
• Villanueva TGR, Humber D, Liberman J, et al. A guide for effective quality improvement: improving acute coronary syndrome care for hospitalized patients. [ cited 2019 Apr 5]. Available from: https://www.hfap.org/pdf/patient_safety.pdf
   Google Scholar
• Shore S, Jones PG, Maddox TM, et al. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart. 2015;101(10):800–807.
   PubMed Web of Science ®Google Scholar
• Pedersen SB, Nielsen JC, Botker HE, et al. Beta-blocker therapy early after myocardial infarction: a comparison between medication at hospital discharge and subsequent pharmacy-dispensed medication. Drugs Real World Outcomes. 2016;3(3):279–288.
   PubMedGoogle Scholar
• Villanueva T. Transitioning the patient with acute coronary syndrome from inpatient to primary care. J Hosp Med. 2010;5(Suppl 4):S8–S14.
   PubMed Web of Science ®Google Scholar
• Bell SP, Schnipper JL, Goggins K, et al. Effect of pharmacist counseling intervention on health care utilization following hospital discharge: a randomized control trial. J Gen Intern Med. 2016;31(5):470–477.
   PubMed Web of Science ®Google Scholar
• Forsyth P, Moir L, Speirits I, et al. Improving medication optimisation in left ventricular systolic dysfunction after acute myocardial infarction. BMJ Open Qual. 2019;8(3):e000676.
   PubMedGoogle Scholar
• National Quality Forum. Safe practices for better healthcare–2010 update: A consensus. [cited 2019 Jul 24]. Available from: https://www.hfap.org/pdf/patient_safety.pdf
   Google Scholar
• Kripalani S, Jackson AT, Schnipper JL, et al. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007;2(5):314–323.
   PubMed Web of Science ®Google Scholar
• Einarsdóttir K, Preen DB, Emery JD, et al. Regular primary care plays a significant role in secondary prevention of ischemic heart disease in a Western Australian cohort. J Gen Intern Med. 2011;26(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Murphy E, Vellinga A, Byrne M, et al. Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis. Br J Gen Pract. 2015;65(636):e460–e468.
   PubMed Web of Science ®Google Scholar
• Dempsey J, Gillis C, Sibicky S, et al. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018;75(17 Supplement 3):S63–S71.
   PubMed Web of Science ®Google Scholar
• American College of Clinical Pharmacy, Hume AL, Kirwin J, et al. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012;32(11):e326–e337.
   PubMed Web of Science ®Google Scholar
• Dorsch MP, Lose JM, DiDomenico RJ. The effect of cardiovascular credentialed pharmacists on process measures and outcomes in myocardial infarction and heart failure. Pharmacotherapy. 2014;34(8):803–808.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Pack QR, Thomas RJ, et al. Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction. Am J Med. 2014;127(6):538–546.
   PubMed Web of Science ®Google Scholar
• Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ. 2015;351:h5000.
   PubMed Web of Science ®Google Scholar
• Thomas RJ, Balady G, Banka G, et al. ACC/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol. 2018;71(16):1814–1837.
   PubMed Web of Science ®Google Scholar
• British Association for Cardiovascular Prevention and Rehabilitation. The BACPR standards and core components for cardiovascular disease prevention and rehabilitation 2017. 3rd ed. London: BACPR; 2017.
   Google Scholar
• Dibao-Dina C, Angoulvant D, Lebeau JP, et al. Patients’ adherence to optimal therapeutic, lifestyle and risk factors recommendations after myocardial infarction: six years follow-up in primary care. PLoS One. 2018;13(9):e0202986.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cao H, Jiang P, et al. Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: a community-based study. Medicine (Baltimore). 2018;97(8):e9785.
   PubMed Web of Science ®Google Scholar
• Bertelsen JB, Refsgaard J, Kanstrup H, et al. Cardiac rehabilitation after acute coronary syndrome comparing adherence and risk factor modification in a community-based shared care model versus hospital-based care in a randomised controlled trial with 12 months of follow-up. Eur J Cardiovasc Nurs. 2017;16(4):334–343.
   PubMed Web of Science ®Google Scholar
• Brieger D, Chow C, Gullick J, et al. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study. Intern Med J. 2018;48(5):541–549.
   PubMed Web of Science ®Google Scholar
• Khatib R, Patel N, Laverty U, et al. Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model. Open Heart. 2018;5(2):e000921.
   PubMed Web of Science ®Google Scholar
• Casper EA, El Wakeel LM, Saleh MA, et al. Management of pharmacotherapy-related problems in acute coronary syndrome: role of clinical pharmacist in cardiac rehabilitation unit. Basic Clin Pharmacol Toxicol. 2019;125(1):44–53.
   PubMed Web of Science ®Google Scholar
• Anchah L, Hassali MA, Lim MS, et al. Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation. Health Qual Life Outcomes. 2017;15(1):10.
   PubMed Web of Science ®Google Scholar
• Doll JA, Hellkamp A, Ho PM, et al. Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction. JAMA Intern Med. 2015;175(10):1700–1702.
   PubMed Web of Science ®Google Scholar
• McMahon SR, Ades PA, Thompson PD. The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med. 2017;27(6):420–425.
   PubMed Web of Science ®Google Scholar
• Peterson ED, Bynum DZ, Roe MT. Association of evidence-based care processes and outcomes among patients with acute coronary syndromes: performance matters. J Cardiovasc Nurs. 2008;23(1):50–55.
   PubMed Web of Science ®Google Scholar
• Rosen OZ, Fridman R, Rosen BT, et al. Medication adherence as a predictor of 30-day hospital readmissions. Patient Prefer Adherence. 2017;11:801–810.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kaplan CM, Baik SH, et al. Medication adherence and readmission after myocardial infarction in the Medicare population. Am J Manag Care. 2014;20(11):e498–e505.
   PubMed Web of Science ®Google Scholar
• Cua YM, Kripalani S. Medication use in the transition from hospital to home. Ann Acad Med Singapore. 2008;37(2):136–141.
   PubMed Web of Science ®Google Scholar
• Gill D, Feldman EA, Liu K. Evaluation of medication compliance for secondary prevention of acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017;30(4):410–412.
   PubMedGoogle Scholar
• Mathews R, Peterson ED, Honeycutt E, et al. Early medication nonadherence after acute myocardial infarction: insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. Circ Cardiovasc Qual Outcomes. 2015;8(4):347–356.
   PubMed Web of Science ®Google Scholar
• El Hajj MS, Jaam MJ, Awaisu A. Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: A systematic review. Res Social Adm Pharm. 2018;14(6):507–520.
   PubMed Web of Science ®Google Scholar
• Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–193.
   PubMed Web of Science ®Google Scholar
• Mathews R, Wang TY, Honeycutt E, et al. Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study. Am Heart J. 2015;170(1):62–69.
   PubMed Web of Science ®Google Scholar
• Lambert-Kerzner A, Havranek EP, Plomondon ME, et al. Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens. Patient Prefer Adherence. 2015;9:1053–1059.
   PubMed Web of Science ®Google Scholar
• Budiman T, Snodgrass K, Komatsu Chang A. Evaluation of pharmacist medication education and post-discharge follow-up in reducing readmissions in patients with ST-segment elevation myocardial infarction (STEMI). Ann Pharmacother. 2016;50(2):118–124.
   PubMed Web of Science ®Google Scholar
• Calvert SB, Kramer JM, Anstrom KJ, et al. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–665 e1.
   PubMed Web of Science ®Google Scholar
• Di Martino M, Alagna M, Cappai G, et al. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design. BMJ Open. 2016;6(4):e010926.
   PubMed Web of Science ®Google Scholar
• Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation. 2001;104(11):1210–1211.
   PubMed Web of Science ®Google Scholar